Repligen Company Leadership
RGEN Stock | USD 167.86 3.42 2.00% |
About 75% of Repligen's corporate insiders are selling. The analysis of insiders' sentiment of trading Repligen stock suggests that many insiders are alarmed at this time. Repligen employs about 1.8 K people. The company is managed by 31 executives with a total tenure of roughly 179 years, averaging almost 5.0 years of service per executive, having 57.52 employees per reported executive.
Anthony Hunt CEO President CEO, Director |
Alexander Rich Chairman Independent Chairman Emeritus of the Board |
Repligen's Insider Buying Vs Selling
25
Selling | Buying |
Latest Trades
2024-03-11 | Ralf Kuriyel | Disposed 3517 @ 193.73 | View | ||
2024-03-08 | Anthony Hunt | Disposed 16707 @ 197.44 | View | ||
2024-02-27 | Karen A Dawes | Disposed 1000 @ 193.35 | View | ||
2024-02-23 | James Bylund | Disposed 4373 @ 198.08 | View | ||
2023-11-10 | Christine Gebski | Disposed 3788 @ 147.13 | View | ||
2023-08-29 | Karen A Dawes | Disposed 850 @ 171.38 | View | ||
2023-05-08 | Martin D Madaus | Acquired 500 @ 156.18 | View | ||
2023-05-04 | Martin D Madaus | Acquired 500 @ 161.15 | View |
Monitoring Repligen's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Repligen |
Repligen's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Repligen's future performance. Based on our forecasts, it is anticipated that Repligen will maintain a workforce of about 1780 employees by May 2024.Repligen's latest congressional trading
Congressional trading in companies like Repligen, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Repligen by those in governmental positions are based on the same information available to the general public.
2022-05-05 | Representative Josh Gottheimer | Acquired Under $15K | Verify |
Repligen Management Team Effectiveness
The company has return on total asset (ROA) of 0.0131 % which means that it generated a profit of $0.0131 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0214 %, meaning that it created $0.0214 on every $100 dollars invested by stockholders. Repligen's management efficiency ratios could be used to measure how well Repligen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of April 2024, Return On Tangible Assets is likely to grow to 0.03. Also, Return On Capital Employed is likely to grow to 0.02. At this time, Repligen's Intangible Assets are very stable compared to the past year. As of the 25th of April 2024, Net Tangible Assets is likely to grow to about 847.1 M, while Deferred Long Term Asset Charges is likely to drop about 2.2 M.As of the 25th of April 2024, Net Income Applicable To Common Shares is likely to grow to about 224.5 M, while Common Stock Shares Outstanding is likely to drop about 29.9 M.
Repligen Workforce Comparison
Repligen is rated third in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 100,507. Repligen claims roughly 1,783 in number of employees contributing just under 2% to equities under Health Care industry.
Repligen Profit Margins
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.5 | 0.445 |
|
|
Repligen Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Repligen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Repligen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Repligen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 0.963 | 26 | 27 | 94,399 | 46,816 |
2023-12-01 | 1.0 | 2 | 2 | 37,142 | 4,788 |
2023-09-01 | 4.0 | 4 | 1 | 30,811 | 850.00 |
2023-06-01 | 4.25 | 17 | 4 | 17,066 | 2,088 |
2023-03-01 | 1.1176 | 19 | 17 | 114,598 | 35,994 |
2022-12-01 | 4.0 | 4 | 1 | 50,932 | 25,000 |
2022-09-01 | 1.2727 | 14 | 11 | 33,358 | 53,098 |
2022-06-01 | 1.7778 | 16 | 9 | 25,152 | 16,809 |
2022-03-01 | 1.087 | 25 | 23 | 118,226 | 39,063 |
2021-12-01 | 0.2333 | 7 | 30 | 21,208 | 42,411 |
2021-09-01 | 0.2368 | 9 | 38 | 66,735 | 66,371 |
2021-06-01 | 0.8824 | 15 | 17 | 28,768 | 49,941 |
2021-03-01 | 0.2 | 11 | 55 | 33,478 | 97,842 |
2020-12-01 | 0.3846 | 5 | 13 | 26,847 | 52,567 |
2020-09-01 | 0.4444 | 4 | 9 | 54,569 | 103,797 |
2020-06-01 | 0.4912 | 28 | 57 | 132,763 | 240,186 |
2020-03-01 | 0.3864 | 17 | 44 | 97,551 | 177,901 |
2019-12-01 | 0.6667 | 2 | 3 | 3,957 | 4,252 |
2019-09-01 | 0.0833 | 1 | 12 | 20,000 | 35,989 |
2019-06-01 | 1.7778 | 16 | 9 | 79,405 | 60,295 |
2019-03-01 | 1.0909 | 12 | 11 | 109,142 | 48,437 |
2018-12-01 | 0.5714 | 4 | 7 | 31,753 | 65,580 |
2018-09-01 | 0.3333 | 5 | 15 | 16,301 | 237,568 |
2018-06-01 | 0.75 | 15 | 20 | 78,022 | 518,257 |
2018-03-01 | 1.2 | 12 | 10 | 620,835 | 49,657 |
2017-12-01 | 0.6 | 3 | 5 | 12,729 | 925,458 |
2017-06-01 | 12.0 | 12 | 1 | 23,373 | 2,275 |
2017-03-01 | 1.0667 | 16 | 15 | 303,765 | 74,292 |
2016-09-01 | 0.5 | 1 | 2 | 20,000 | 3,024 |
2016-06-01 | 2.125 | 17 | 8 | 68,062 | 51,493 |
2016-03-01 | 2.0 | 10 | 5 | 178,940 | 6,484 |
2015-12-01 | 3.0 | 3 | 1 | 7,000 | 5,000 |
2015-09-01 | 1.0 | 1 | 1 | 24,000 | 325.00 |
2015-06-01 | 1.4 | 14 | 10 | 26,388 | 232,625 |
2015-03-01 | 1.25 | 10 | 8 | 119,519 | 128,483 |
2014-12-01 | 0.625 | 5 | 8 | 62,000 | 126,158 |
2014-09-01 | 1.0 | 3 | 3 | 20,000 | 45,000 |
2014-06-01 | 0.9459 | 35 | 37 | 514,181 | 589,312 |
2014-03-01 | 10.0 | 10 | 1 | 142,524 | 40,000 |
2013-09-01 | 0.3333 | 1 | 3 | 50,000 | 109,858 |
2013-06-01 | 0.5455 | 18 | 33 | 310,016 | 504,087 |
2013-03-01 | 1.2857 | 9 | 7 | 385,000 | 179,973 |
2012-09-01 | 0.3333 | 8 | 24 | 102,000 | 400,000 |
2012-03-01 | 0.3846 | 5 | 13 | 160,000 | 341,551 |
2011-09-01 | 2.0 | 2 | 1 | 31,000 | 25,000 |
2011-03-01 | 0.25 | 1 | 4 | 5,000 | 85,000 |
2009-09-01 | 1.25 | 5 | 4 | 104,000 | 451,800 |
2008-09-01 | 3.0 | 6 | 2 | 109,000 | 10,000 |
2008-03-01 | 0.1304 | 3 | 23 | 115,000 | 76,368 |
2007-12-01 | 0.5556 | 10 | 18 | 155,400 | 92,600 |
2007-09-01 | 3.5 | 7 | 2 | 860,000 | 139,465 |
2007-06-01 | 1.2857 | 9 | 7 | 127,000 | 89,444 |
2007-03-01 | 0.3571 | 5 | 14 | 160,000 | 78,000 |
2006-09-01 | 2.2 | 11 | 5 | 108,000 | 65,000 |
2006-03-01 | 0.8333 | 15 | 18 | 596,500 | 236,400 |
2005-12-01 | 2.0 | 6 | 3 | 17,000 | 36,576 |
2005-09-01 | 0.4615 | 6 | 13 | 85,000 | 60,425 |
2005-06-01 | 6.0 | 6 | 1 | 175,000 | 15,000 |
2005-03-01 | 2.5 | 5 | 2 | 45,000 | 20,000 |
2004-09-01 | 6.0 | 6 | 1 | 85,000 | 24,000 |
2004-06-01 | 1.75 | 7 | 4 | 220,000 | 25,000 |
2004-03-01 | 0.5 | 1 | 2 | 5,000 | 5,000 |
2003-12-01 | 1.25 | 20 | 16 | 140,000 | 128,000 |
Repligen Notable Stakeholders
A Repligen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Repligen often face trade-offs trying to please all of them. Repligen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Repligen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
About Repligen Management Performance
The success or failure of an entity such as Repligen often depends on how effective the management is. Repligen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Repligen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Repligen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.03 | 0.03 | |
Return On Capital Employed | 0.02 | 0.02 | |
Return On Assets | 0.01 | 0.02 | |
Return On Equity | 0.02 | 0.02 |
The data published in Repligen's official financial statements usually reflect Repligen's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Repligen. For example, before you start analyzing numbers published by Repligen accountants, it's critical to develop an understanding of what Repligen's liquidity, profitability, and earnings quality are in the context of the Life Sciences Tools & Services space in which it operates.
Please note, the presentation of Repligen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Repligen's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Repligen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Repligen. Please utilize our Beneish M Score to check the likelihood of Repligen's management manipulating its earnings.
Repligen Workforce Analysis
Traditionally, organizations such as Repligen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Repligen within its industry.Repligen Manpower Efficiency
Return on Repligen Manpower
Revenue Per Employee | 358.3K | |
Revenue Per Executive | 20.6M | |
Net Income Per Employee | 23.3K | |
Net Income Per Executive | 1.3M | |
Working Capital Per Employee | 534.4K | |
Working Capital Per Executive | 30.7M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Repligen Stock analysis
When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.55) | Earnings Share 0.74 | Revenue Per Share 11.464 | Quarterly Revenue Growth (0.17) | Return On Assets 0.0131 |
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.